The Patent Finder

Terms ending in 2027

Optinose Inc.

Every in-force patent on Optinose Inc.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,124,132Nasal Delivery
In force
 · High confidence
OptiNose Inc.In forceHigh confidence
US 7,854,227Nasal Devices
In force
 · High confidence
OptiNose Inc.In forceHigh confidence
US 10,112,021Intranasal Administration
In force
 · High confidence
OptiNose Inc.In forceHigh confidence
US 10,864,334Nasal Delivery
In force
 · High confidence
OptiNose Inc.In forceHigh confidence
US 10,737,045Delivery Devices
In force
 · High confidence
OptiNose Inc.In forceHigh confidence
US 10,398,859Nasal Delivery Devices
In force
 · High confidence
OptiNose Inc.In forceHigh confidence
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited